Skip to content

Insider · CIK 0001242177

Richard L Lindstrom Md

director

Files at LNSR (LENSAR, Inc.), OCUL (OCULAR THERAPEUTIX, INC). First filing May 12, 2025, latest May 12, 2025.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$70k bought, $0 sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

OCUL: OCULAR THERAPEUTIX, INC

OCULOct 9, 2026 · close 7.54

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
34Weak
OCULbuy
OCULAR THERAPEUTIX, INC
$70k
10,000 shares
+6%+26% from low-35% from high

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Jun 11, 2025OCUL
OCULAR THERAPEUTIX, INC
AGrant or award
Common Stock
+14,000$0.00$0143,145Jun 13, 2025
Jun 11, 2025OCUL
OCULAR THERAPEUTIX, INC
AGrant or award
Stock Option (Right to Buy)derivative
+44,000$0.00$044,000Jun 13, 2025
May 23, 2025LNSR
LENSAR, Inc.
AGrant or award
Common Stock
+7,374$0.00$0246,410May 28, 2025
May 8, 2025OCUL
OCULAR THERAPEUTIX, INC
POpen-market purchase
Common Stock
+10,000$6.96$70k172,704May 12, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Richard L Lindstrom Md: insider trades and track record | InsiderTell